Aaron Royston - Oct 20, 2021 Form 3/A - Amendment Insider Report for Ventyx Biosciences, Inc. (VTYX)

Role
Director
Signature
/s/ Christopher Krueger, as Attorney-in-Fact
Stock symbol
VTYX
Transactions as of
Oct 20, 2021
Transactions value $
$0
Form type
3/A - Amendment
Date filed
9/14/2022, 05:00 PM
Date Of Original Report
Oct 20, 2021
Next filing
Oct 25, 2021

No securities are beneficially owned.

Remarks:

This amendment to Form 3 is being filed to correctly report that the Reporting Person does not beneficially own any of the Issuer's securities held directly by venBio SPV III, LLC or venBio Global Strategic Fund III, L.P. Such shares were inadvertently included in the Form 3 filed by the Reporting Person on October 20, 2021 and the Form 4 filed by the Reporting Person on October 25, 2021.